FDA Investigator Paul P Geraci

Paul P Geraci has conducted inspections on 240 sites in 2 countries as of 25 Oct 2012. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
240
Last Inspection Date:
25 Oct 2012
Investigator Role:
FDA Investigator
Redica ID:
100006151
Countries of Inspections:
United States of America, Switzerland
FDA Investigators that have inspected at least one site in common with Paul P Geraci:
Abby E Pelletier, Alan R Condon, Alice C Silva, Althea A Williams, Alysia M Salonia, Amber G Wardwell, Amy C Jordan, Andre S Lamontagne, Andrea A Branche, Andrew J Seaborn, Andrew P Abban, Ashley A Mutawakkil, Barbara Janine Breithaupt, Bradford L Swanson, Brenda P King, Camerson E Moore, Carla C Tuite, Constance Desimone, Daniel J Lahar, Darin S Wiegers, David P Vanhouten, Dawn M Braswell, Deborah A Greco, Dolores Harper, Dorothy W Lee, Douglas S Joslin, Edward J Janik, Elizabeth B Griffin, Elizabeth D Connell, Ellen P Madigan, Eric C Schmitt, Esteban Beltran, Garry H Stewart, Gary J Hagan, George T Allen, Jr, Gerald T O'connor, Guozhou Mo, Ian A Pilcher, James H Tanner, James P Finn, James W Whitney, Jason A Rossi, Jeanne F Broderick, Jeffrey R Alling, Jeffrey S Buckser, John A Sciacchitano, John P Shelton, John R Carlson, John S Hartford, Jonathan B Lewis, Jonathan G Matrisciano, Jose A Torres, Joyce A Kellett, Justine M Corson, Karen Mcnabb Noon, Katarzyna Plona, Kathleen E Mcafoose, Kent A Conforti, Kristina J Donohue, Kristina M Joyce, Lauren M Lawrance, Lauren M Mclaughlin, Laurie B Frazier, LCDR Debra Emerson, Lori A Holmquist, Lori M Newman, Louis Christy, Marcia M Laughrey, Margaret M Annes, Mark K Tseng, Marlene L Davis, Martin J Guardia, Mary Jeanet Mcgarry, Mary P Murphy, Maryam Tabatabaie, Matthew C Watson, Maura Rooney, Max Lager, Megan A Haggerty, Michael G Mayfield, Michael J Leal, Michael P Anthony, Michael P Sweeney, Michelle M Noe Varga, Monique C Lo, Mutahar S Shamsi, Nabil Nakhoul, Nadia R Barreda, Nassim Ben Makhlouf, Osama A Khatib, Paraluman S Leonin, Paula M Laplant, Peter Abel, Philip H Lafleur, Philip Kreiter, Ramon E Martinez, Rebecca A Coleman, Richard F Hapke, Richard H Penta, Robert O'brian, Rory K Geyer, Rupa Pradhan, Sandra P White, Sara M Onyango, Scott B Laufenberg, Sean M Tessicini, Sean R Marcsisin, Seth A Mailhot, Slater K Bartlett, Stacey S Degarmo, Stephen C King, Stephen C Smith, Stephen R Souza, Sunita Pandey, Susan T Hadman, Susanne M Richardson, MS RAC, Suzanne M Healy, Tamara S Rosbury, Terry C Kimball, Todd J Maushart, William S Boivin

Paul P Geraci's Documents

Publish Date Document Type Title
April, 2002 FDA 483 Pierce Instruments, Inc. - Form 483, 2002-04-16
April, 2000 EIR Tambrands, Inc. - EIR, 2000-04-12
October, 2002 FDA 483 WYETH RESEARCH - Form 483, 2002-10-30
June, 2001 EIR AIRGAS USA, LLC - EIR, 2001-06-21
April, 2012 FDA 483 Kat Implants, LLC - Form 483, 2012-04-23
September, 2003 FDA 483 Access CardioSystems - Form 483, 2003-09-24
January, 2004 FDA 483 Access CardioSystems - Form 483, 2004-01-30
June, 2010 FDA 483 The Prometheus Group - Form 483, 2010-06-02
September, 2000 EIR ZOLL Medical Corporation - EIR, 2000-09-27
January, 2010 FDA 483 Guidewire Technologies, Inc. - Form 483, 2010-01-22
November, 2004 EIR Access CardioSystems - EIR, 2004-11-05
April, 2003 EIR Vermed, Inc. - EIR, 2003-04-21
January, 2004 EIR Access CardioSystems - EIR, 2004-01-30
April, 2001 EIR Smith & Nephew, Inc., Endoscopy Div. - EIR, 2001-04-11
December, 2010 FDA 483 Vygon MFG, Inc., dba/ Churchill Medical Systems, Inc. - Form 483, 2010-12-17
April, 2002 EIR Pierce Instruments, Inc. - EIR, 2002-04-16
December, 2011 FDA 483 Vascular Technology, Inc. - Form 483, 2011-12-22
September, 2003 EIR Access CardioSystems - EIR, 2003-09-24
March, 2001 EIR Belmont Instrument Corporation - EIR, 2001-03-27
April, 2003 FDA 483 Vermed, Inc. - Form 483, 2003-04-21

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more